ArticleJournal of the American Society of Nephrology : JASN2014
Phospholipase A2 receptor antibodies in membranous nephropathy: unresolved issues.
Article in Journal of the American Society of Nephrology : JASN, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- PLA2R-Positive Membranous Nephropathy and AA Amyloidosis in an Ethiopian Patient With Chronic Hepatitis B: A Case Report.Clinical case reports · 2026Article
- Membranous Nephropathy: Antigenic Landscape and a Novel Pathogenetic Model.International journal of molecular sciences · 2026Review
- Circulating miRNAs in extracellular vesicles related to treatment response in patients with idiopathic membranous nephropathy.Journal of translational medicine · 2022Article
- Intrarenal Single-Cell Sequencing of Hepatitis B Virus Associated Membranous Nephropathy.Frontiers in medicine · 2022Article
- Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy.Journal of the American Society of Nephrology : JASN · 2020Article
- Article
- Comparative analysis of membranous and other nephropathy subtypes and establishment of a diagnostic model.Frontiers of medicine · 2019Article
- Recurrent andFrontiers in immunology · 2019Review
- Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy.Vascular health and risk management · 2018Article
- Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.BioMed research international · 2018Review
- Diagnostic Test Accuracy of Serum Anti-PLA2R Autoantibodies and Glomerular PLA2R Antigen for Diagnosing Idiopathic Membranous Nephropathy: An Updated Meta-Analysis.Frontiers in medicine · 2018Article
- PLA2R and THSD7A: Disparate Paths to the Same Disease?Journal of the American Society of Nephrology : JASN · 2017Review
- Primary Membranous Nephropathy.Clinical journal of the American Society of Nephrology : CJASN · 2017Review
- M-type phospholipase APediatric nephrology (Berlin, Germany) · 2017Article
- Membranous Nephropathy: A Journey From Bench to Bedside.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2016Review
- Antiphospholipase A2 receptor autoantibody guided diagnosis and treatment of membranous nephropathy: a new personalized medical approach.Clinical journal of the American Society of Nephrology : CJASN · 2014Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.